Wilkinson George Fred
Insider CIK 1356685 · IPXL Chief Executive Officer, Director · ACT PRES-ACTAVIS SPECIALTY BRANDS · WPI Pres-Global Brands&Biosimilars
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2016-04-29 | 2016-12-23 | 97,219 | $33.35 | $3.24M | 429,237 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2016-04-29 | 2016-05-02 | 61,594 | $33.35 | $2.05M | 464,862 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award deriv | 2016-02-26 | 2016-03-01 | 215,851 | — | $0 | 215,851 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2016-02-26 | 2016-03-01 | 5,567 | $33.27 | $185.2K | 437,124 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2016-02-26 | 2016-03-01 | 89,332 | — | $0 | 526,456 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2015-10-29 | 2015-10-30 | 16,425 | $35.75 | $587.2K | 442,691 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2015-04-29 | 2015-05-01 | 114,803 | $46.36 | $5.32M | 459,116 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award deriv | 2015-02-26 | 2015-03-12 | 162,000 | — | $0 | 162,000 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2015-02-26 | 2015-03-12 | 68,000 | — | $0 | 573,919 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | F Tax w/h | 2014-10-29 | 2014-10-31 | 19,081 | $28.19 | $537.9K | 505,919 | SEC↗ |
| IPXL IMPAX LABORATORIES INC | A Award | 2014-05-06 | 2014-05-08 | 525,000 | — | $0 | 525,000 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-27 | 2013-12-02 | 24,217 | $165.00 | $4.00M | 15,412 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-25 | 2013-11-26 | 1,502 | $165.00 | $247.8K | 39,629 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-22 | 2013-11-26 | 4,281 | $165.00 | $706.4K | 41,131 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 45,412 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2013-10-01 | 2013-10-03 | 45,412 | — | $0 | 45,412 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-09-30 | 2013-10-02 | 43,429 | $144.00 | $6.25M | 45,412 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-09-30 | 2013-10-02 | 39,612 | — | $0 | 88,841 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-09-21 | 2013-09-24 | 3,240 | $135.50 | $439.0K | 49,229 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-09-04 | 2013-09-06 | 16,749 | $138.00 | $2.31M | 52,469 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 6,716 | — | $0 | 69,218 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 7,369 | — | $0 | 62,502 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-03-02 | 2013-03-05 | 5,554 | $85.54 | $475.1K | 55,133 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-10-31 | 2012-11-02 | 2,909 | — | $0 | 60,687 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 10,027 | — | $0 | 50,651 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 7,127 | — | $0 | 57,778 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | F Tax w/h | 2012-02-24 | 2012-02-28 | 1,956 | $58.17 | $113.8K | 40,624 | SEC↗ |